You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Ayano Satsuka1, Alexandre J S Ribeiro2, Hiroyuki Kawagishi1
1Division of Pharmacology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa 210-9501, Japan.
Aligned human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) on nanopatterned plates show improved contractility and drug response. This enhanced model offers a better way to assess drug-induced cardiac contractile dysfunction during drug development.
10:30Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Published on: August 4, 2022
05:06Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
Published on: May 5, 2020
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: